XML 75 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details) (USD $)
In Millions, unless otherwise specified
Mar. 31, 2014
Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents $ 94.7 $ 0
Trading securities 16.8 16.6
Foreign exchange derivative assets 3.2 6.4
Total assets at recurring fair value measurement 1,793.4 1,536.4
Foreign exchange derivative liabilities 8.8 58.5
Total liabilities at recurring fair value measurement 2,217.4 2,041.9
Purchased cash convertible note hedge
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,535.1 1,303.0
Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative liabilities 0.4 15.8
Cash conversion feature of Cash Convertible Notes
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,535.1 1,303.0
Contingent consideration
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 673.1 664.6
Money market funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 94.7 0
Equity securities — exchange traded funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 16.8 16.6
Available-for-sale fixed income investments
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 27.4 26.8
U.S. Treasuries
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.7 12.8
Corporate bonds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 11.1 10.7
Agency mortgage-backed securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 13.2 0.7
Other
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 2.4 2.6
Total available-for-sale equity securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.1 0.2
Biosciences industry
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.1 0.2
Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative assets 116.1 183.4
Level 1
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 94.7 0
Trading securities 16.8 16.6
Total assets at recurring fair value measurement 111.6 16.8
Level 1 | Money market funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 94.7 0
Level 1 | Equity securities — exchange traded funds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 16.8 16.6
Level 1 | Total available-for-sale equity securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.1 0.2
Level 1 | Biosciences industry
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.1 0.2
Level 2
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign exchange derivative assets 3.2 6.4
Total assets at recurring fair value measurement 1,681.8 1,519.6
Foreign exchange derivative liabilities 8.8 58.5
Total liabilities at recurring fair value measurement 1,544.3 1,377.3
Level 2 | Purchased cash convertible note hedge
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,535.1 1,303.0
Level 2 | Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative liabilities 0.4 15.8
Level 2 | Cash conversion feature of Cash Convertible Notes
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Convertible debt, fair value disclosures 1,535.1 1,303.0
Level 2 | Available-for-sale fixed income investments
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 27.4 26.8
Level 2 | U.S. Treasuries
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 0.7 12.8
Level 2 | Corporate bonds
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 11.1 10.7
Level 2 | Agency mortgage-backed securities
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 13.2 0.7
Level 2 | Other
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale securities 2.4 2.6
Level 2 | Interest rate swaps
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Interest rate swap derivative assets 116.1 183.4
Level 3
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities at recurring fair value measurement 673.1 664.6
Level 3 | Contingent consideration
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration $ 673.1 $ 664.6